Pentraxin 3 as a novel biomarker of lung injury; evidence from a human one-lung ventilation model

Shelley, B., MacFie, A., Tanner, O., Galley, H. and Kinsella, J. (2014) Pentraxin 3 as a novel biomarker of lung injury; evidence from a human one-lung ventilation model. In: 44th Critical Care Congress, Society of Critical Care Medicine, Phoenix, AZ, USA, 17-21 Jan 2015, (doi:10.1097/01.ccm.0000458184.19563.5b)

Full text not currently available from Enlighten.

Publisher's URL: http://www.sccm.org/Education-Center/Annual-Congress/Pages/default.aspx

Abstract

Putative properties of the ‘ideal’ lung injury biomarker include high sensitivity and specificity, variation in proportion to the severity of injury and association with clinically important outcomes. We tested the performance of the novel lung injury biomarker Pentraxin 3 (PTX3) against these properties in a human one-lung ventilation (OLV) model of lung injury. PTX3 is produced locally in the lung in response to tissue injury and has a biologically plausible role in the pathogenesis of lung injury.

Item Type:Conference Proceedings
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Shelley, Dr Ben and MacFie, Dr Alistair and Kinsella, Professor John
Authors: Shelley, B., MacFie, A., Tanner, O., Galley, H., and Kinsella, J.
Subjects:R Medicine > R Medicine (General)
College/School:College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing

University Staff: Request a correction | Enlighten Editors: Update this record